Tanis, B C
Multicenter phase II study of spiroplatin. [electronic resource]
- Oncology 1992
- 99-103 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0030-2414
10.1159/000227020 doi
Antineoplastic Agents--adverse effects
Drug Evaluation
Humans
Kidney Diseases--chemically induced
Leukocyte Count--drug effects
Neoplasms--drug therapy
Organoplatinum Compounds--adverse effects
Platelet Count--drug effects